Login
Super Investors iShares Global Healthcare ETF

iShares Global Healthcare ETF

Ishares Trust · net assets $3.84B · 124 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 98.7% · STIV: 1.3% · OTHER: 0.0% · DE: 0.0%

Financial position

Total assets
$3.89B
Total liabilities
$42.2M
Net assets
$3.84B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$62K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $80M $0 $131M
Reinvestment $0 $0 $0
Redemptions $61.1M $9.19M $99.8M
Net realized gain (non-derivative) $17.2M $762K $23.7M
Net unrealized appreciation (non-derivative) $-48.1M $53.6M $150M

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Ishares Trust
Registrant CIK
1100663
Registrant LEI
5493000860OXIC4B5K91
Series
iShares Global Healthcare ETF
Series ID
S000004372
Series LEI
5493008DMA8OZ7F0WV53
SEC file number
811-09729
Address
400 Howard Street, San Francisco, US-CA, 94105, US
Phone
800-474-2737
Form
NPORT-P
Filed
August 24, 2026
Report period ends
March 31, 2027
Report month ends
June 30, 2026
Accession number
000100472626007010
Holding Value % of net assets
Eli Lilly And Company EC $420M 10.93%
Johnson & Johnson EC $271M 7.04%
Abbvie Inc. EC $197M 5.12%
Unitedhealth Group Incorporated EC $169M 4.40%
Merck & Co., Inc. EC $158M 4.12%
Astrazeneca PLC EC $145M 3.76%
Roche Holding Ag EC $144M 3.75%
Novartis Ag EC $143M 3.71%
Amgen Inc. EC $97.5M 2.54%
Thermo Fisher Scientific Incorporated EC $93M 2.42%
Abbott Laboratories EC $78.9M 2.05%
Gilead Sciences, Inc. EC $78.3M 2.04%
Novo Nordisk A/s EC $76.4M 1.99%
Intuitive Surgical, Inc. EC $70.3M 1.83%
Pfizer Inc. EC $68.5M 1.78%
Cvs Health Corporation EC $65.9M 1.71%
Vertex Pharmaceuticals Incorporated EC $62.9M 1.64%
Danaher Corporation EC $59.9M 1.56%
Bristol-myers Squibb Company EC $58.7M 1.53%
Stryker Corporation EC $54.2M 1.41%
Gsk PLC EC $53.1M 1.38%
Medtronic Public Limited Company EC $50.1M 1.30%
Sanofi Sa EC $45.5M 1.18%
Mckesson Corporation EC $45.3M 1.18%
Elevance Health, Inc. EC $41.9M 1.09%
Blackrock Funds Iii: Blackrock Cash Funds: Institutional; Sl Agency Shares STIV $40.6M 1.06%
The Cigna Group EC $36.4M 0.95%
Boston Scientific Corporation EC $31.7M 0.82%
Regeneron Pharmaceuticals, Inc. EC $31.1M 0.81%
Hca Healthcare, Inc. EC $30.2M 0.79%
Argenx Se EC $28.6M 0.74%
Cardinal Health, Inc. EC $27.8M 0.72%
Cencora, Inc. EC $27.5M 0.71%
Essilorluxottica Sa EC $27.4M 0.71%
Bayer Aktiengesellschaft EC $27.1M 0.71%
Hoya Corporation EC $26.9M 0.70%
Edwards Lifesciences Corporation EC $26M 0.68%
Takeda Pharmaceutical Company Limited EC $25.3M 0.66%
Humana Inc. EC $23.8M 0.62%
Lonza Group Ag EC $23.6M 0.61%
Galderma Group Ag EC $20.8M 0.54%
Idexx Laboratories, Inc. EC $20.7M 0.54%
Becton, Dickinson And Company EC $20.7M 0.54%
Haleon PLC EC $20.4M 0.53%
Sandoz Group Ag EC $19.8M 0.52%
Csl Limited EC $19.3M 0.50%
Agilent Technologies, Inc. EC $18.7M 0.49%
Waters Corporation EC $18.4M 0.48%
Ucb Sa EC $18M 0.47%
Otsuka Holdings Co., Ltd. EC $17.1M 0.44%
Alcon Ag EC $16.8M 0.44%
Iqvia Holdings Inc EC $16.1M 0.42%
Biogen Inc. EC $15.9M 0.41%
Daiichi Sankyo Company, Limited EC $15.2M 0.40%
Zoetis Inc. EC $15M 0.39%
Centene Corporation EC $15M 0.39%
Chugai Pharmaceutical Co., Ltd. EC $14.7M 0.38%
Ge Healthcare Technologies Inc. EC $14.5M 0.38%
Resmed Inc. EC $14.1M 0.37%
Veeva Systems Inc. EC $13.3M 0.35%

Showing top 60 of 124 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support